Cargando…
Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis
Dapsone (DDS), Rifampicin (RIF) and Ofloxacin (OFL) are drugs recommended by the World Health Organization (WHO) for the treatment of leprosy. In the context of leprosy, resistance to these drugs occurs mainly due to mutations in the target genes (Folp1, RpoB and GyrA). It is important to monitor an...
Autores principales: | Li, Xiang, Li, Guoli, Yang, Jing, Jin, Guangjie, Shao, Yuting, Li, Yunhui, Wei, Pingmin, Zhang, Lianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604410/ https://www.ncbi.nlm.nih.gov/pubmed/36293307 http://dx.doi.org/10.3390/ijms232012443 |
Ejemplares similares
-
Epidemiological characteristics of leprosy during the period 2005–2020: A retrospective study based on the Chinese surveillance system
por: Li, Xiang, et al.
Publicado: (2023) -
A Bibliometric Analysis of Leprosy during 2000–2021 from Web of Science Database
por: Li, Xiang, et al.
Publicado: (2022) -
Dapsone-induced Methemoglobinemia in a Patient of Leprosy
por: Das, Joyjit, et al.
Publicado: (2015) -
Clofazimine/dapsone/rifampicin: Lepra reactions: 3 case reports
Publicado: (2021) -
Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010–2012
por: Williams, Diana L., et al.
Publicado: (2018)